Author Question: A woman who takes highly active antiretroviral therapy (HAART) for HIV/AIDS has become pregnant. ... (Read 57 times)

elizabeth18 · **on:** Jul 23, 2018

A woman who takes highly active antiretroviral therapy (HAART) for HIV/AIDS has become pregnant. What effect will the woman's pregnancy have on her drug regimen?

A) She must discontinue HAART due to the risk of teratogenic effects.
B) Her dosages of HAART must be increased to reduce the risk of in utero transmission.
C) She can continue her HAART unchanged.
D) Some components of her HAART must be replaced or discontinued.

Question 2

A nurse is educating a patient on the administration of tinidazole (Tindamax). Which of the following indicates that the patient understands the administration of tinidazole?

A) I will report to the doctor if I have a slow heart rate.
B) The medicine will leave a bitter or metallic taste in my mouth.
C) I will report urinary urgency and incontinence.
D) The medication is given in two doses every day.

KKcool · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

C
Feedback:
Antiretroviral drug therapy for the pregnant woman reduces perinatal transmission by about two thirds. In general, highly active antiretroviral therapy, or HAART, is safe, with recommended dosage the same as for nonpregnant women.

Answer to Question 2

B
Feedback:
Tinidazole (Tindamax) will produce a bitter or metallic taste in the mouth. Tinidazole will cause tachycardia as an adverse effect. Tinidazole will cause urinary retention, not urgency. Tinidazole should be administered in one dose, not two doses.